Effect of parenteral aminoglycoside administration on dark cells in the crista ampullaris

Archives of Otolaryngology - Head and Neck Surgery

Volumn 129, Issue 6, 2003, Pages 626-628

  Cureoglu, Sebahattin ^a,b   Schachern, Patricia A ^a   Paparella, Michael M ^a,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b International Hearing Foundation   (United States)

^c Minnesota Ear Head and Neck Clinic ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; KANAMYCIN; TOBRAMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DESTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INNER EAR DISEASE; MICROSCOPY; MORTALITY; OTOTOXICITY; TEMPORAL BONE;

ADOLESCENT; ADULT; AGED; AMINOGLYCOSIDES; HUMANS; INFUSIONS, PARENTERAL; MIDDLE AGED; SEMICIRCULAR CANALS; TEMPORAL BONE; TIME FACTORS;

EID: 0038241926     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.129.6.626     Document Type: Article

References (22)

1. Schuknecht HF. Pathology of the Ear. 2nd ed. Media, Pa: Lea & Febiger; 1993.
2. Stringer SP, Meyerhoff WL, Wright CG. Ototoxicity. In: Paparella MM, Shumrick DA, Gluckman JL, Meyerhoff WL, eds. Otolaryngology. Vol 2. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1991:1653-1669.
3. Schuknecht HF. Ablation therapy in the management of Ménière's disease. Acta Otolaryngol Suppl. 1957;132:1-42.
4. Silverstein H, Hyman SM, Feldbaum J, Silverstein D. Use of streptomycin sulfate in the treatment of Ménière's disease. Otolaryngol Head Neck Surg. 1984; 92:229-232.
5. Moretz WH Jr, Shea JJ Jr, Orchik DJ, Emmett JR, Shea JJ III. Streptomycin treatment in Ménière's disease. Otolaryngol Head Neck Surg. 1987;96:256-259.
6. Laitakari K. Intratympanic gentamicin in severe Ménière's disease. Clin Otolaryngol. 1990;15:545-548.
7. Hirsch BE, Kamerer DB. Intratympanic gentamicin therapy for Ménière's disease. Am J Otol. 1997;18:44-51.
8. Nedzelski JM, Chiong CM, Fradet G, et al. Intratympanic gentamicin instillation as treatment of unilateral Ménière's disease: update of an ongoing study. Am J Otol. 1993;14:278-282.
9. Shea JJ, Ge X. Streptomycin perfusion of the labyrinth through the round window plus intravenous streptomycin. Otolaryngol Clin North Am. 1994;27:317-324.
10. Pender DJ. Gentamicin tympanoclysis: effects on the vestibular secretory cells. Am J Otolaryngol. 1985;6:358-367.
11. Park JC, Cohen GM. Vestibular ototoxicity in the chick: effects of streptomycin on equilibrium and on ampullary dark cells. Am J Otolaryngol. 1982;3:117-127.
12. Ge X, Shea JJ. Intramuscular streptomycin effect on dark cells of utricle in guinea pigs. Am J Otol. 1993;14:74-78.
13. Tsuji K, Velazquez-Villasenor L, Rauch SD, Glynn RJ, Wall C III, Merchant SN. Temporal bone studies of the human peripheral vestibular system: amiglycoside ototoxicity. Ann Otol Rhinol Laryngol Suppl. 2000;181:20-25.
14. Masutani H, Takahashi H, Sando I. Dark cell pathology in Ménière's disease. Acta Otolaryngol (Stockh). 1992;112:479-485.
15. Kimura RS. Distribution, structure, and function of dark cells in the vestibular labyrinth. Ann Otol Rhinol Laryngol. 1969;78:542-561.
16. Yoshihara T, Kaname H, Ishii T, Igarashi M. Effect of gentamycin on vestibular dark cells and melanocytes: an ultrastructural and cytochemical study. ORJ Otorhinolaryngol Relat Spec. 1994;56:24-30,
17. Wangemann P. Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cells. Hear Res. 1995;90:149-157.
18. Hawkins JE Jr, Preston RE. Vestibular ototoxicity. In: Naunton RF, ed. The Vestibular System. Orlando, Fla: Academic Press Inc; 1975:321-349.
19. Meza G, Lopez I, Paredes MA, Penatoza Y, Pobtano A. Cellular target of streptomycin in the internal ear. Acta Otolaryngol (Stockh). 1989;107:406-411.
20. Lindeman HH. Regional differences in sensitivity of the vestibular sensory epithelia to ototoxic antibiotics. Acta Otolaryngol (Stockh). 1969;67:177-189.
21. Slattery WH, Fayad JN. Medical treatment of Ménière's disease. Otolaryngol Clin North Am. 1997;30:1027-1037.
22. Konishi T, Mori H. Permeability to sodium ions of the endolymph-perilymph barrier. Hear Res. 1984;15:143-149.